ATNM·00507W206·US·equity·Healthcare - Biotechnology-13D/G
ATNM (ACTINIUM PHARMACEUTICALS INC) is held by 31 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($561,946), RENAISSANCE TECHNOLOGIES LLC ($469,383), BlackRock, Inc. ($369,466). Net institutional sentiment: Mixed.
See how ATNM's score breaks down across 4 SEC sources
Showing 1-20 of 39
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer